Cargando…
Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy
Acquired therapeutic resistance by tumors is a substantial impediment to reducing the morbidity and mortality that are attributable to human malignancies. The mechanisms responsible for the dramatic shift between chemosensitivity and chemoresistance in colorectal carcinoma have not been defined. Her...
Autores principales: | Li, Xiaolei, Wu, Zhiqiang, An, Xiaojing, Mei, Qian, Bai, Miaomiao, Hanski, Leena, Li, Xiang, Ahola, Tero, Han, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562444/ https://www.ncbi.nlm.nih.gov/pubmed/28820388 http://dx.doi.org/10.7554/eLife.27301 |
Ejemplares similares
-
Correction: Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy
por: Li, Xiaolei, et al.
Publicado: (2020) -
An LRP16-containing preassembly complex contributes to NF-κB activation induced by DNA double-strand breaks
por: Wu, Zhiqiang, et al.
Publicado: (2015) -
LRP16 Integrates into NF-κB Transcriptional Complex and Is Required for Its Functional Activation
por: Wu, Zhiqiang, et al.
Publicado: (2011) -
The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma
por: Liu, Jin, et al.
Publicado: (2020) -
Development and validation of LRP1B mutation-associated prognostic model for hepatocellular carcinoma
por: Xu, Jian, et al.
Publicado: (2021)